secwatch.observer — SEC 8-K summary
======================================

Issuer:     SAFEGUARD SCIENTIFICS INC (SFES)
CIK:        0000086115
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001437749-22-011133
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Safeguard Scientifics Q1 net loss $6.7M; strategic review with Houlihan Lokey continues
--------------------------------------------------------------------------------

- Net loss $6.7M ($0.40 per share) vs net income $17.6M ($0.84 per share) in Q1 2021.
- Repurchased 147,795 shares at avg $5.27 in Q1; additional $0.4M post-quarter at $4.71.
- Funded $2.0M convertible loan to Prognos Health and $1.4M to Clutch Holdings.
- Carrying value of ownership interests $24.1M vs cost $154.4M; Bright Health fair value $2.6M.
- Strategic review with Houlihan Lokey ongoing; update expected by Q3 2022 earnings call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/86115/000143774922011133/0001437749-22-011133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/86115/000143774922011133/sfe20220504_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-011133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer